Improving medication safety for older adults with chronic kidney disease
Official title: (R01) Strengthening the Evidence-Base to Support Medication Prescribing in Older Adults with Chronic Kidney Disease
Funded at Rutgers Biomedical and Health Sciences · NIH-11050147 · Data updated 2026-11-12
This study is looking at how certain heart and diabetes medications affect older adults with chronic kidney disease, to make sure they are safe and work well for this group of people who often get left out of research.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | January 27, 2025 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $671,986 |
| NIH project number | 1R01DK139163-01A1 |
| Project ID | NIH-11050147 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 65 and above who have been diagnosed with chronic kidney disease.
✕Less likely to help
Patients under the age of 65 or those without chronic kidney disease may not benefit from this research.
What this research studies
This research investigates how medications affect older adults with chronic kidney disease (CKD), a condition that impacts a significant portion of this age group. The study aims to evaluate the safety and effectiveness of commonly prescribed cardiometabolic drugs, particularly focusing on those that may pose risks or are under-researched in this population. By analyzing data from the Veterans Affairs system and electronic health records, the research will compare the effects of different medications on kidney function and overall health outcomes. This approach seeks to fill the gap left by previous clinical trials that often exclude older adults with CKD.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medication prescribing practices for older adults with chronic kidney disease.
How similar studies have gone: Previous research has highlighted the need for better medication management in older adults with chronic conditions, indicating that this approach could yield valuable insights.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Dave, Chintan — Rutgers Biomedical and Health Sciences
- Study coordinator: Dave, Chintan
Related research
Other NIH-funded projects on the same topics.
-
Personalized CKD-MBD care using systems biology and AI
A patient-facing program aims to tailor mineral-balance therapy for people with chronic kidney disease by using a computer model and smart decision rules to predict who will respond best to treatments.
-
Mitigating DKA in people with type 1 diabetes and kidney disease using SGLT1/2 inhibitors
This project tests a new way to prevent dangerous diabetic ketoacidosis in people with type 1 diabetes and chronic kidney disease who are using SGLT inhibitors, by tracking ketones in real time and combining glucose-keton data for safer therapy.
-
Chronic Kidney Disease in Children: following young people as they grow up with CKD
A long-term study in kids with chronic kidney disease tracks kidney function and heart health as they transition into adulthood.
-
Chronic Kidney Disease in Children follow-up study
A long-term study that follows kids with kidney disease as they grow into young adults, collecting health data from home and official records.
-
Malaria-related kidney injury and its link to chronic kidney disease in children
This grant looks at why some children who have malaria develop kidney injury and later chronic kidney disease, focusing on how severe malaria affects the kidneys over time.
-
Boosting self-care and physical activity for older adults with chronic kidney disease
This program helps older adults with chronic kidney disease build the skills, confidence, and motivation to be more physically active.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.